Literature DB >> 28289010

Response by Methawasin and Granzier to Letter Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction".

Mei Methawasin1, Henk Granzier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28289010      PMCID： PMC5401660          DOI： 10.1161/CIRCULATIONAHA.117.026955

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.

Authors:  Mei Methawasin; Joshua G Strom; Rebecca E Slater; Vanessa Fernandez; Chandra Saripalli; Henk Granzier
Journal:  Circulation       Date:  2016-09-14       Impact factor: 29.690

Review 2.  Titin: physiological function and role in cardiomyopathy and failure.

Authors:  Henk Granzier; Yiming Wu; Labeit Siegfried; Martin LeWinter
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

Review 3.  Therapeutic targets in heart failure: refocusing on the myocardial interstitium.

Authors:  Erik B Schelbert; Gregg C Fonarow; Robert O Bonow; Javed Butler; Mihai Gheorghiade
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

Review 4.  Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

Authors:  Michael R Zile; Catalin F Baicu
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

5.  Reducing RBM20 activity improves diastolic dysfunction and cardiac atrophy.

Authors:  Florian Hinze; Christoph Dieterich; Michael H Radke; Henk Granzier; Michael Gotthardt
Journal:  J Mol Med (Berl)       Date:  2016-11-26       Impact factor: 4.599
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.